We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Therapeutic Target Found to Stop Cancer Metastases

By LabMedica International staff writers
Posted on 06 May 2010
Scientists have uncovered what could be a very important lead in answering one of the most mystifying questions about cancer: why does it spread to the liver more than any other organ? In new research, scientists revealed experimental results suggesting that the immune system may be the explanation.

"Our work may open a new field of experimental therapeutics as combating the eventual development of liver metastases by targeting immune suppressive cells in the livers, in patients with early cancer can have great benefit,” said Dr. George Miller, a scientist involved in the work from the departments of surgery and cell biology at the New York University School of Medicine (New York, NY, USA).

Dr. Miller and colleagues reached this conclusion after conducting experiments in lab mice. In the experiments, the investigators used mice that spontaneously developed pancreatic cancer because of a mutation (Kras-mutation) in the progenitor cells of the pancreas, as well as mice with advanced colon cancers that spread to the abdomen. They then studied the expansion of immune suppressive cells in the liver from a very early stage in the cancer development to determine the immune phenotype, stimulus for recruitment, inhibitory effects, and tumor-enabling function of these cells. The study's results suggest that fighting immune suppressive cells in the liver early after cancer development may prevent the metastasis of cancer to this vital organ.

The study's findings were published in the April 2010 issue of Journal of Leukocyte Biology (JLB). "This study could represent one of those ‘a-ha' moments in science where one idea or experiment opens up entirely new ways of approaching and understanding a problem,” said Luis Montaner, editor-in-chief of JLB. "Physicians have known that the spread of cancer to the liver is far too common to occur by chance. Now we know that the immune system likely plays a role in facilitating this process. The next step, obviously, is to learn more so we can prevent it from happening.”

Related Links:
New York University School of Medicine



Gold Member
Quality Control Material
iPLEX Pro Exome QC Panel
POC Helicobacter Pylori Test Kit
Hepy Urease Test
New
CMV CLIA Diagnostic
CLIA CMV IgA Screen Group
New
Chromogenic Culture System
InTray™ COLOREX™ ECC

Latest BioResearch News

Study Links Midlife Vitamin D to Lower Tau in Alzheimer's
06 May 2010  |   BioResearch

International Consensus Standardizes Tumor Microbiota Detection and Reporting
06 May 2010  |   BioResearch

Common Metablolic Enzyme Could Predict Response to Cancer Immunotherapy
06 May 2010  |   BioResearch